Diosmin
This article was originally published in The Tan Sheet
Executive Summary
Nutratech's premarket notification for new dietary ingredient for venal health supplement rejected by FDA in mid-June. Diosmin already is sold in the U.S. and internationally, the Fairfield, N.J.-based marketer says. In a June 16 letter, the agency voices "significant concerns" about safety. Nutratech has since submitted additional clarification and clinical data to FDA